Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.70
- Piotroski Score 6.00
- Grade Buy
- Symbol (ACAD)
- Company ACADIA Pharmaceuticals Inc.
- Price $15.10
- Changes Percentage (2.58%)
- Change $0.38
- Day Low $14.73
- Day High $15.13
- Year High $32.59
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $26.00
- High Stock Price Target $62.00
- Low Stock Price Target $15.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.37
- Trailing P/E Ratio -40.24
- Forward P/E Ratio -40.24
- P/E Growth -40.24
- Net Income $-61,286,000
Income Statement
Quarterly
Annual
Latest News of ACAD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Cause of death revealed for 19-year-old Air Force Academy cadet found...
Cadet Avery Koonce of the US Air Force Academy died of pneumonia that went untreated, leading to sepsis and her tragic death at 19. Medical expert Dr. Michael Baden believes it was preventable with an...
By New York Post | 1 day ago -
Cause of Death Revealed for 19-Year-Old Air Force Academy Cadet Who Was Found Unconscious in Dorm
Anna Lazarus Caplan is a writer-reporter at PEOPLE since 2022. Avery Koonce, a 19-year-old USAFA cadet, died from a rare anaerobic bacteria causing sepsis....
By PEOPLE.com | 1 day ago -
Cowboys' Eric Kendricks visits Texas Can Academy, promotes education and community support
Eric Kendricks, Cowboys linebacker, visited Texas Can Academy in Pleasant Grove in partnership with Cars for Kids. He engaged with students, shared his story, and the nonprofit donated $850,000 to sup...
By CBS News | 5 days ago
